Company page

Outlook Therapeutics, Inc.

Outlook Therapeutics, Inc. is a public company traded under the ticker OTLK in the American market. The company has a market capitalization of approximately $253 million. Outlook Therapeutics focuses on developing innovative therapies to address unmet medical needs.

profileOTLK:NASDAQAI content: aiUpdated June 24, 2026/company/outlook-therapeutics-inc/c-encnlzxp
Outlook Therapeutics, Inc. logo
Ticker
OTLK:NASDAQ
Asset type
Stock
Market cap
$253.0M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD